Global Genetically Modified Drug Market Research Report 2024, Forecast to 2032
Report Overview
Drugs made by genetically modified means are also called 'biological drugs'
The global Genetically Modified Drug market size was estimated at USD 2314 million in 2023 and is projected to reach USD 3909.45 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Genetically Modified Drug market size was estimated at USD 666.58 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Genetically Modified Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genetically Modified Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genetically Modified Drug market in any manner.
Global Genetically Modified Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Market Segmentation (by Type)
Transgenic Animal
Transgenic Plant
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetically Modified Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetically Modified Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Drugs made by genetically modified means are also called 'biological drugs'
The global Genetically Modified Drug market size was estimated at USD 2314 million in 2023 and is projected to reach USD 3909.45 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
North America Genetically Modified Drug market size was estimated at USD 666.58 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Genetically Modified Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Genetically Modified Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Genetically Modified Drug market in any manner.
Global Genetically Modified Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Market Segmentation (by Type)
Transgenic Animal
Transgenic Plant
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Genetically Modified Drug Market
- Overview of the regional outlook of the Genetically Modified Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Genetically Modified Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Genetically Modified Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Genetically Modified Drug
1.2 Key Market Segments
1.2.1 Genetically Modified Drug Segment by Type
1.2.2 Genetically Modified Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETICALLY MODIFIED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genetically Modified Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Genetically Modified Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETICALLY MODIFIED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Genetically Modified Drug Sales by Manufacturers (2019-2024)
3.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genetically Modified Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genetically Modified Drug Sales Sites, Area Served, Product Type
3.6 Genetically Modified Drug Market Competitive Situation and Trends
3.6.1 Genetically Modified Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genetically Modified Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENETICALLY MODIFIED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Genetically Modified Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETICALLY MODIFIED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetically Modified Drug Sales Market Share by Type (2019-2024)
6.3 Global Genetically Modified Drug Market Size Market Share by Type (2019-2024)
6.4 Global Genetically Modified Drug Price by Type (2019-2024)
7 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetically Modified Drug Market Sales by Application (2019-2024)
7.3 Global Genetically Modified Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
8 GENETICALLY MODIFIED DRUG MARKET CONSUMPTION BY REGION
8.1 Global Genetically Modified Drug Sales by Region
8.1.1 Global Genetically Modified Drug Sales by Region
8.1.2 Global Genetically Modified Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Genetically Modified Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genetically Modified Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genetically Modified Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genetically Modified Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genetically Modified Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 GENETICALLY MODIFIED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Genetically Modified Drug by Region (2019-2024)
9.2 Global Genetically Modified Drug Revenue Market Share by Region (2019-2024)
9.3 Global Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Genetically Modified Drug Production
9.4.1 North America Genetically Modified Drug Production Growth Rate (2019-2024)
9.4.2 North America Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Genetically Modified Drug Production
9.5.1 Europe Genetically Modified Drug Production Growth Rate (2019-2024)
9.5.2 Europe Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Genetically Modified Drug Production (2019-2024)
9.6.1 Japan Genetically Modified Drug Production Growth Rate (2019-2024)
9.6.2 Japan Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Genetically Modified Drug Production (2019-2024)
9.7.1 China Genetically Modified Drug Production Growth Rate (2019-2024)
9.7.2 China Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 LFB Biotechnologies SA
10.1.1 LFB Biotechnologies SA Genetically Modified Drug Basic Information
10.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Overview
10.1.3 LFB Biotechnologies SA Genetically Modified Drug Product Market Performance
10.1.4 LFB Biotechnologies SA Business Overview
10.1.5 LFB Biotechnologies SA Genetically Modified Drug SWOT Analysis
10.1.6 LFB Biotechnologies SA Recent Developments
10.2 Pharming Group NV
10.2.1 Pharming Group NV Genetically Modified Drug Basic Information
10.2.2 Pharming Group NV Genetically Modified Drug Product Overview
10.2.3 Pharming Group NV Genetically Modified Drug Product Market Performance
10.2.4 Pharming Group NV Business Overview
10.2.5 Pharming Group NV Genetically Modified Drug SWOT Analysis
10.2.6 Pharming Group NV Recent Developments
10.3 Pfizer
10.3.1 Pfizer Genetically Modified Drug Basic Information
10.3.2 Pfizer Genetically Modified Drug Product Overview
10.3.3 Pfizer Genetically Modified Drug Product Market Performance
10.3.4 Pfizer Genetically Modified Drug SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Roche
10.4.1 Roche Genetically Modified Drug Basic Information
10.4.2 Roche Genetically Modified Drug Product Overview
10.4.3 Roche Genetically Modified Drug Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Genetically Modified Drug Basic Information
10.5.2 Abbott Laboratories Genetically Modified Drug Product Overview
10.5.3 Abbott Laboratories Genetically Modified Drug Product Market Performance
10.5.4 Abbott Laboratories Business Overview
10.5.5 Abbott Laboratories Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Genetically Modified Drug Basic Information
10.6.2 Johnson and Johnson Genetically Modified Drug Product Overview
10.6.3 Johnson and Johnson Genetically Modified Drug Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck and Co.
10.7.1 Merck and Co. Genetically Modified Drug Basic Information
10.7.2 Merck and Co. Genetically Modified Drug Product Overview
10.7.3 Merck and Co. Genetically Modified Drug Product Market Performance
10.7.4 Merck and Co. Business Overview
10.7.5 Merck and Co. Recent Developments
10.8 Amgen
10.8.1 Amgen Genetically Modified Drug Basic Information
10.8.2 Amgen Genetically Modified Drug Product Overview
10.8.3 Amgen Genetically Modified Drug Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 F. Hoffmann-La Roche
10.9.1 F. Hoffmann-La Roche Genetically Modified Drug Basic Information
10.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Overview
10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product Market Performance
10.9.4 F. Hoffmann-La Roche Business Overview
10.9.5 F. Hoffmann-La Roche Recent Developments
10.10 Sanofi
10.10.1 Sanofi Genetically Modified Drug Basic Information
10.10.2 Sanofi Genetically Modified Drug Product Overview
10.10.3 Sanofi Genetically Modified Drug Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Novartis
10.11.1 Novartis Genetically Modified Drug Basic Information
10.11.2 Novartis Genetically Modified Drug Product Overview
10.11.3 Novartis Genetically Modified Drug Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Genetically Modified Drug Basic Information
10.12.2 Eli Lilly Genetically Modified Drug Product Overview
10.12.3 Eli Lilly Genetically Modified Drug Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Takeda
10.13.1 Takeda Genetically Modified Drug Basic Information
10.13.2 Takeda Genetically Modified Drug Product Overview
10.13.3 Takeda Genetically Modified Drug Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 Baxter
10.14.1 Baxter Genetically Modified Drug Basic Information
10.14.2 Baxter Genetically Modified Drug Product Overview
10.14.3 Baxter Genetically Modified Drug Product Market Performance
10.14.4 Baxter Business Overview
10.14.5 Baxter Recent Developments
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Genetically Modified Drug Basic Information
10.15.2 GlaxoSmithKline Genetically Modified Drug Product Overview
10.15.3 GlaxoSmithKline Genetically Modified Drug Product Market Performance
10.15.4 GlaxoSmithKline Business Overview
10.15.5 GlaxoSmithKline Recent Developments
11 GENETICALLY MODIFIED DRUG MARKET FORECAST BY REGION
11.1 Global Genetically Modified Drug Market Size Forecast
11.2 Global Genetically Modified Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genetically Modified Drug Market Size Forecast by Country
11.2.3 Asia Pacific Genetically Modified Drug Market Size Forecast by Region
11.2.4 South America Genetically Modified Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Genetically Modified Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Genetically Modified Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Genetically Modified Drug by Type (2025-2032)
12.1.2 Global Genetically Modified Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Genetically Modified Drug by Type (2025-2032)
12.2 Global Genetically Modified Drug Market Forecast by Application (2025-2032)
12.2.1 Global Genetically Modified Drug Sales (K MT) Forecast by Application
12.2.2 Global Genetically Modified Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Genetically Modified Drug
1.2 Key Market Segments
1.2.1 Genetically Modified Drug Segment by Type
1.2.2 Genetically Modified Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENETICALLY MODIFIED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Genetically Modified Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Genetically Modified Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENETICALLY MODIFIED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Genetically Modified Drug Sales by Manufacturers (2019-2024)
3.2 Global Genetically Modified Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Genetically Modified Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Genetically Modified Drug Sales Sites, Area Served, Product Type
3.6 Genetically Modified Drug Market Competitive Situation and Trends
3.6.1 Genetically Modified Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Genetically Modified Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENETICALLY MODIFIED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Genetically Modified Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENETICALLY MODIFIED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Genetically Modified Drug Sales Market Share by Type (2019-2024)
6.3 Global Genetically Modified Drug Market Size Market Share by Type (2019-2024)
6.4 Global Genetically Modified Drug Price by Type (2019-2024)
7 GENETICALLY MODIFIED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Genetically Modified Drug Market Sales by Application (2019-2024)
7.3 Global Genetically Modified Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
8 GENETICALLY MODIFIED DRUG MARKET CONSUMPTION BY REGION
8.1 Global Genetically Modified Drug Sales by Region
8.1.1 Global Genetically Modified Drug Sales by Region
8.1.2 Global Genetically Modified Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Genetically Modified Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Genetically Modified Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Genetically Modified Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Genetically Modified Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Genetically Modified Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 GENETICALLY MODIFIED DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Genetically Modified Drug by Region (2019-2024)
9.2 Global Genetically Modified Drug Revenue Market Share by Region (2019-2024)
9.3 Global Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Genetically Modified Drug Production
9.4.1 North America Genetically Modified Drug Production Growth Rate (2019-2024)
9.4.2 North America Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Genetically Modified Drug Production
9.5.1 Europe Genetically Modified Drug Production Growth Rate (2019-2024)
9.5.2 Europe Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Genetically Modified Drug Production (2019-2024)
9.6.1 Japan Genetically Modified Drug Production Growth Rate (2019-2024)
9.6.2 Japan Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Genetically Modified Drug Production (2019-2024)
9.7.1 China Genetically Modified Drug Production Growth Rate (2019-2024)
9.7.2 China Genetically Modified Drug Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 LFB Biotechnologies SA
10.1.1 LFB Biotechnologies SA Genetically Modified Drug Basic Information
10.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Overview
10.1.3 LFB Biotechnologies SA Genetically Modified Drug Product Market Performance
10.1.4 LFB Biotechnologies SA Business Overview
10.1.5 LFB Biotechnologies SA Genetically Modified Drug SWOT Analysis
10.1.6 LFB Biotechnologies SA Recent Developments
10.2 Pharming Group NV
10.2.1 Pharming Group NV Genetically Modified Drug Basic Information
10.2.2 Pharming Group NV Genetically Modified Drug Product Overview
10.2.3 Pharming Group NV Genetically Modified Drug Product Market Performance
10.2.4 Pharming Group NV Business Overview
10.2.5 Pharming Group NV Genetically Modified Drug SWOT Analysis
10.2.6 Pharming Group NV Recent Developments
10.3 Pfizer
10.3.1 Pfizer Genetically Modified Drug Basic Information
10.3.2 Pfizer Genetically Modified Drug Product Overview
10.3.3 Pfizer Genetically Modified Drug Product Market Performance
10.3.4 Pfizer Genetically Modified Drug SWOT Analysis
10.3.5 Pfizer Business Overview
10.3.6 Pfizer Recent Developments
10.4 Roche
10.4.1 Roche Genetically Modified Drug Basic Information
10.4.2 Roche Genetically Modified Drug Product Overview
10.4.3 Roche Genetically Modified Drug Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Abbott Laboratories
10.5.1 Abbott Laboratories Genetically Modified Drug Basic Information
10.5.2 Abbott Laboratories Genetically Modified Drug Product Overview
10.5.3 Abbott Laboratories Genetically Modified Drug Product Market Performance
10.5.4 Abbott Laboratories Business Overview
10.5.5 Abbott Laboratories Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Genetically Modified Drug Basic Information
10.6.2 Johnson and Johnson Genetically Modified Drug Product Overview
10.6.3 Johnson and Johnson Genetically Modified Drug Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 Merck and Co.
10.7.1 Merck and Co. Genetically Modified Drug Basic Information
10.7.2 Merck and Co. Genetically Modified Drug Product Overview
10.7.3 Merck and Co. Genetically Modified Drug Product Market Performance
10.7.4 Merck and Co. Business Overview
10.7.5 Merck and Co. Recent Developments
10.8 Amgen
10.8.1 Amgen Genetically Modified Drug Basic Information
10.8.2 Amgen Genetically Modified Drug Product Overview
10.8.3 Amgen Genetically Modified Drug Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 F. Hoffmann-La Roche
10.9.1 F. Hoffmann-La Roche Genetically Modified Drug Basic Information
10.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Overview
10.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product Market Performance
10.9.4 F. Hoffmann-La Roche Business Overview
10.9.5 F. Hoffmann-La Roche Recent Developments
10.10 Sanofi
10.10.1 Sanofi Genetically Modified Drug Basic Information
10.10.2 Sanofi Genetically Modified Drug Product Overview
10.10.3 Sanofi Genetically Modified Drug Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Novartis
10.11.1 Novartis Genetically Modified Drug Basic Information
10.11.2 Novartis Genetically Modified Drug Product Overview
10.11.3 Novartis Genetically Modified Drug Product Market Performance
10.11.4 Novartis Business Overview
10.11.5 Novartis Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Genetically Modified Drug Basic Information
10.12.2 Eli Lilly Genetically Modified Drug Product Overview
10.12.3 Eli Lilly Genetically Modified Drug Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Takeda
10.13.1 Takeda Genetically Modified Drug Basic Information
10.13.2 Takeda Genetically Modified Drug Product Overview
10.13.3 Takeda Genetically Modified Drug Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 Baxter
10.14.1 Baxter Genetically Modified Drug Basic Information
10.14.2 Baxter Genetically Modified Drug Product Overview
10.14.3 Baxter Genetically Modified Drug Product Market Performance
10.14.4 Baxter Business Overview
10.14.5 Baxter Recent Developments
10.15 GlaxoSmithKline
10.15.1 GlaxoSmithKline Genetically Modified Drug Basic Information
10.15.2 GlaxoSmithKline Genetically Modified Drug Product Overview
10.15.3 GlaxoSmithKline Genetically Modified Drug Product Market Performance
10.15.4 GlaxoSmithKline Business Overview
10.15.5 GlaxoSmithKline Recent Developments
11 GENETICALLY MODIFIED DRUG MARKET FORECAST BY REGION
11.1 Global Genetically Modified Drug Market Size Forecast
11.2 Global Genetically Modified Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Genetically Modified Drug Market Size Forecast by Country
11.2.3 Asia Pacific Genetically Modified Drug Market Size Forecast by Region
11.2.4 South America Genetically Modified Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Genetically Modified Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Genetically Modified Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Genetically Modified Drug by Type (2025-2032)
12.1.2 Global Genetically Modified Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Genetically Modified Drug by Type (2025-2032)
12.2 Global Genetically Modified Drug Market Forecast by Application (2025-2032)
12.2.1 Global Genetically Modified Drug Sales (K MT) Forecast by Application
12.2.2 Global Genetically Modified Drug Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genetically Modified Drug Market Size Comparison by Region (M USD)
Table 5. Global Genetically Modified Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Genetically Modified Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Genetically Modified Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Genetically Modified Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
Table 10. Global Market Genetically Modified Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Genetically Modified Drug Sales Sites and Area Served
Table 12. Manufacturers Genetically Modified Drug Product Type
Table 13. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Genetically Modified Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genetically Modified Drug Market Challenges
Table 22. Global Genetically Modified Drug Sales by Type (K MT)
Table 23. Global Genetically Modified Drug Market Size by Type (M USD)
Table 24. Global Genetically Modified Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Genetically Modified Drug Sales Market Share by Type (2019-2024)
Table 26. Global Genetically Modified Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Genetically Modified Drug Market Size Share by Type (2019-2024)
Table 28. Global Genetically Modified Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Genetically Modified Drug Sales (K MT) by Application
Table 30. Global Genetically Modified Drug Market Size by Application
Table 31. Global Genetically Modified Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Genetically Modified Drug Sales Market Share by Application (2019-2024)
Table 33. Global Genetically Modified Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Genetically Modified Drug Market Share by Application (2019-2024)
Table 35. Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Genetically Modified Drug Sales Market Share by Region (2019-2024)
Table 38. North America Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Genetically Modified Drug Production (K MT) by Region (2019-2024)
Table 44. Global Genetically Modified Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Genetically Modified Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. LFB Biotechnologies SA Genetically Modified Drug Basic Information
Table 52. LFB Biotechnologies SA Genetically Modified Drug Product Overview
Table 53. LFB Biotechnologies SA Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. LFB Biotechnologies SA Business Overview
Table 55. LFB Biotechnologies SA Genetically Modified Drug SWOT Analysis
Table 56. LFB Biotechnologies SA Recent Developments
Table 57. Pharming Group NV Genetically Modified Drug Basic Information
Table 58. Pharming Group NV Genetically Modified Drug Product Overview
Table 59. Pharming Group NV Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Pharming Group NV Business Overview
Table 61. Pharming Group NV Genetically Modified Drug SWOT Analysis
Table 62. Pharming Group NV Recent Developments
Table 63. Pfizer Genetically Modified Drug Basic Information
Table 64. Pfizer Genetically Modified Drug Product Overview
Table 65. Pfizer Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Pfizer Genetically Modified Drug SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Roche Genetically Modified Drug Basic Information
Table 70. Roche Genetically Modified Drug Product Overview
Table 71. Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Roche Business Overview
Table 73. Roche Recent Developments
Table 74. Abbott Laboratories Genetically Modified Drug Basic Information
Table 75. Abbott Laboratories Genetically Modified Drug Product Overview
Table 76. Abbott Laboratories Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Recent Developments
Table 79. Johnson and Johnson Genetically Modified Drug Basic Information
Table 80. Johnson and Johnson Genetically Modified Drug Product Overview
Table 81. Johnson and Johnson Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Recent Developments
Table 84. Merck and Co. Genetically Modified Drug Basic Information
Table 85. Merck and Co. Genetically Modified Drug Product Overview
Table 86. Merck and Co. Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Merck and Co. Business Overview
Table 88. Merck and Co. Recent Developments
Table 89. Amgen Genetically Modified Drug Basic Information
Table 90. Amgen Genetically Modified Drug Product Overview
Table 91. Amgen Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. F. Hoffmann-La Roche Genetically Modified Drug Basic Information
Table 95. F. Hoffmann-La Roche Genetically Modified Drug Product Overview
Table 96. F. Hoffmann-La Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. F. Hoffmann-La Roche Business Overview
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Sanofi Genetically Modified Drug Basic Information
Table 100. Sanofi Genetically Modified Drug Product Overview
Table 101. Sanofi Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sanofi Business Overview
Table 103. Sanofi Recent Developments
Table 104. Novartis Genetically Modified Drug Basic Information
Table 105. Novartis Genetically Modified Drug Product Overview
Table 106. Novartis Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Eli Lilly Genetically Modified Drug Basic Information
Table 110. Eli Lilly Genetically Modified Drug Product Overview
Table 111. Eli Lilly Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Takeda Genetically Modified Drug Basic Information
Table 115. Takeda Genetically Modified Drug Product Overview
Table 116. Takeda Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Takeda Business Overview
Table 118. Takeda Recent Developments
Table 119. Baxter Genetically Modified Drug Basic Information
Table 120. Baxter Genetically Modified Drug Product Overview
Table 121. Baxter Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Baxter Business Overview
Table 123. Baxter Recent Developments
Table 124. GlaxoSmithKline Genetically Modified Drug Basic Information
Table 125. GlaxoSmithKline Genetically Modified Drug Product Overview
Table 126. GlaxoSmithKline Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. GlaxoSmithKline Business Overview
Table 128. GlaxoSmithKline Recent Developments
Table 129. Global Genetically Modified Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Genetically Modified Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Genetically Modified Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Genetically Modified Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Genetically Modified Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Genetically Modified Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Genetically Modified Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Genetically Modified Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Genetically Modified Drug Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Genetically Modified Drug Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Genetically Modified Drug Market Size Comparison by Region (M USD)
Table 5. Global Genetically Modified Drug Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Genetically Modified Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Genetically Modified Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Genetically Modified Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Modified Drug as of 2022)
Table 10. Global Market Genetically Modified Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Genetically Modified Drug Sales Sites and Area Served
Table 12. Manufacturers Genetically Modified Drug Product Type
Table 13. Global Genetically Modified Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Genetically Modified Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Genetically Modified Drug Market Challenges
Table 22. Global Genetically Modified Drug Sales by Type (K MT)
Table 23. Global Genetically Modified Drug Market Size by Type (M USD)
Table 24. Global Genetically Modified Drug Sales (K MT) by Type (2019-2024)
Table 25. Global Genetically Modified Drug Sales Market Share by Type (2019-2024)
Table 26. Global Genetically Modified Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Genetically Modified Drug Market Size Share by Type (2019-2024)
Table 28. Global Genetically Modified Drug Price (USD/MT) by Type (2019-2024)
Table 29. Global Genetically Modified Drug Sales (K MT) by Application
Table 30. Global Genetically Modified Drug Market Size by Application
Table 31. Global Genetically Modified Drug Sales by Application (2019-2024) & (K MT)
Table 32. Global Genetically Modified Drug Sales Market Share by Application (2019-2024)
Table 33. Global Genetically Modified Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Genetically Modified Drug Market Share by Application (2019-2024)
Table 35. Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 37. Global Genetically Modified Drug Sales Market Share by Region (2019-2024)
Table 38. North America Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 39. Europe Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 41. South America Genetically Modified Drug Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Genetically Modified Drug Sales by Region (2019-2024) & (K MT)
Table 43. Global Genetically Modified Drug Production (K MT) by Region (2019-2024)
Table 44. Global Genetically Modified Drug Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Genetically Modified Drug Revenue Market Share by Region (2019-2024)
Table 46. Global Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Genetically Modified Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. LFB Biotechnologies SA Genetically Modified Drug Basic Information
Table 52. LFB Biotechnologies SA Genetically Modified Drug Product Overview
Table 53. LFB Biotechnologies SA Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. LFB Biotechnologies SA Business Overview
Table 55. LFB Biotechnologies SA Genetically Modified Drug SWOT Analysis
Table 56. LFB Biotechnologies SA Recent Developments
Table 57. Pharming Group NV Genetically Modified Drug Basic Information
Table 58. Pharming Group NV Genetically Modified Drug Product Overview
Table 59. Pharming Group NV Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Pharming Group NV Business Overview
Table 61. Pharming Group NV Genetically Modified Drug SWOT Analysis
Table 62. Pharming Group NV Recent Developments
Table 63. Pfizer Genetically Modified Drug Basic Information
Table 64. Pfizer Genetically Modified Drug Product Overview
Table 65. Pfizer Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Pfizer Genetically Modified Drug SWOT Analysis
Table 67. Pfizer Business Overview
Table 68. Pfizer Recent Developments
Table 69. Roche Genetically Modified Drug Basic Information
Table 70. Roche Genetically Modified Drug Product Overview
Table 71. Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Roche Business Overview
Table 73. Roche Recent Developments
Table 74. Abbott Laboratories Genetically Modified Drug Basic Information
Table 75. Abbott Laboratories Genetically Modified Drug Product Overview
Table 76. Abbott Laboratories Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Recent Developments
Table 79. Johnson and Johnson Genetically Modified Drug Basic Information
Table 80. Johnson and Johnson Genetically Modified Drug Product Overview
Table 81. Johnson and Johnson Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Recent Developments
Table 84. Merck and Co. Genetically Modified Drug Basic Information
Table 85. Merck and Co. Genetically Modified Drug Product Overview
Table 86. Merck and Co. Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Merck and Co. Business Overview
Table 88. Merck and Co. Recent Developments
Table 89. Amgen Genetically Modified Drug Basic Information
Table 90. Amgen Genetically Modified Drug Product Overview
Table 91. Amgen Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Amgen Business Overview
Table 93. Amgen Recent Developments
Table 94. F. Hoffmann-La Roche Genetically Modified Drug Basic Information
Table 95. F. Hoffmann-La Roche Genetically Modified Drug Product Overview
Table 96. F. Hoffmann-La Roche Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. F. Hoffmann-La Roche Business Overview
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Sanofi Genetically Modified Drug Basic Information
Table 100. Sanofi Genetically Modified Drug Product Overview
Table 101. Sanofi Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Sanofi Business Overview
Table 103. Sanofi Recent Developments
Table 104. Novartis Genetically Modified Drug Basic Information
Table 105. Novartis Genetically Modified Drug Product Overview
Table 106. Novartis Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Novartis Business Overview
Table 108. Novartis Recent Developments
Table 109. Eli Lilly Genetically Modified Drug Basic Information
Table 110. Eli Lilly Genetically Modified Drug Product Overview
Table 111. Eli Lilly Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Eli Lilly Business Overview
Table 113. Eli Lilly Recent Developments
Table 114. Takeda Genetically Modified Drug Basic Information
Table 115. Takeda Genetically Modified Drug Product Overview
Table 116. Takeda Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Takeda Business Overview
Table 118. Takeda Recent Developments
Table 119. Baxter Genetically Modified Drug Basic Information
Table 120. Baxter Genetically Modified Drug Product Overview
Table 121. Baxter Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Baxter Business Overview
Table 123. Baxter Recent Developments
Table 124. GlaxoSmithKline Genetically Modified Drug Basic Information
Table 125. GlaxoSmithKline Genetically Modified Drug Product Overview
Table 126. GlaxoSmithKline Genetically Modified Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. GlaxoSmithKline Business Overview
Table 128. GlaxoSmithKline Recent Developments
Table 129. Global Genetically Modified Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Genetically Modified Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Genetically Modified Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Genetically Modified Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Genetically Modified Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Genetically Modified Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Genetically Modified Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Genetically Modified Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Genetically Modified Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Genetically Modified Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Genetically Modified Drug Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Genetically Modified Drug Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Genetically Modified Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetically Modified Drug Market Size (M USD), 2019-2032
Figure 5. Global Genetically Modified Drug Market Size (M USD) (2019-2032)
Figure 6. Global Genetically Modified Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genetically Modified Drug Market Size by Country (M USD)
Figure 11. Genetically Modified Drug Sales Share by Manufacturers in 2023
Figure 12. Global Genetically Modified Drug Revenue Share by Manufacturers in 2023
Figure 13. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Genetically Modified Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Genetically Modified Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Genetically Modified Drug Market Share by Type
Figure 18. Sales Market Share of Genetically Modified Drug by Type (2019-2024)
Figure 19. Sales Market Share of Genetically Modified Drug by Type in 2023
Figure 20. Market Size Share of Genetically Modified Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Genetically Modified Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genetically Modified Drug Market Share by Application
Figure 24. Global Genetically Modified Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Genetically Modified Drug Sales Market Share by Application in 2023
Figure 26. Global Genetically Modified Drug Market Share by Application (2019-2024)
Figure 27. Global Genetically Modified Drug Market Share by Application in 2023
Figure 28. Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Genetically Modified Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Genetically Modified Drug Sales Market Share by Country in 2023
Figure 32. U.S. Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Genetically Modified Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Genetically Modified Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Genetically Modified Drug Sales Market Share by Country in 2023
Figure 37. Germany Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Genetically Modified Drug Sales Market Share by Region in 2023
Figure 44. China Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 50. South America Genetically Modified Drug Sales Market Share by Country in 2023
Figure 51. Brazil Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Genetically Modified Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Genetically Modified Drug Production Market Share by Region (2019-2024)
Figure 62. North America Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Genetically Modified Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Genetically Modified Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Genetically Modified Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Genetically Modified Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Genetically Modified Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Genetically Modified Drug Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Genetically Modified Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Genetically Modified Drug Market Size (M USD), 2019-2032
Figure 5. Global Genetically Modified Drug Market Size (M USD) (2019-2032)
Figure 6. Global Genetically Modified Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Genetically Modified Drug Market Size by Country (M USD)
Figure 11. Genetically Modified Drug Sales Share by Manufacturers in 2023
Figure 12. Global Genetically Modified Drug Revenue Share by Manufacturers in 2023
Figure 13. Genetically Modified Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Genetically Modified Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Genetically Modified Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Genetically Modified Drug Market Share by Type
Figure 18. Sales Market Share of Genetically Modified Drug by Type (2019-2024)
Figure 19. Sales Market Share of Genetically Modified Drug by Type in 2023
Figure 20. Market Size Share of Genetically Modified Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Genetically Modified Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Genetically Modified Drug Market Share by Application
Figure 24. Global Genetically Modified Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Genetically Modified Drug Sales Market Share by Application in 2023
Figure 26. Global Genetically Modified Drug Market Share by Application (2019-2024)
Figure 27. Global Genetically Modified Drug Market Share by Application in 2023
Figure 28. Global Genetically Modified Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Genetically Modified Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Genetically Modified Drug Sales Market Share by Country in 2023
Figure 32. U.S. Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Genetically Modified Drug Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Genetically Modified Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Genetically Modified Drug Sales Market Share by Country in 2023
Figure 37. Germany Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Genetically Modified Drug Sales Market Share by Region in 2023
Figure 44. China Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 50. South America Genetically Modified Drug Sales Market Share by Country in 2023
Figure 51. Brazil Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Genetically Modified Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Genetically Modified Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Genetically Modified Drug Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Genetically Modified Drug Production Market Share by Region (2019-2024)
Figure 62. North America Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 65. China Genetically Modified Drug Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Genetically Modified Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Genetically Modified Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Genetically Modified Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Genetically Modified Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Genetically Modified Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Genetically Modified Drug Market Share Forecast by Application (2025-2032)
